Jakarta, March 28, 2014 – PT Kalbe Farma Tbk and its subsidiaries (“Kalbe” or “the Company”) today announced the Company’s performance for the year 2013 based on the audited consolidated financial statement for the year ended December 31, 2013. Consolidated sales reached Rp 16.0 Trillion for year 2013, an increase of approximately 17.3% compared to Rp 13.6 Trillion last year.

Jakarta, March 21, 2014 – Kalbe is proud to present Indonesia’s first health beverage for skin care, Diva, as the latest addition to our nutritionals product line-up. Diva provides a complete combination of skin nutrients featuring collagen, super fruits and vitamins E and A. Collagen content will improve skin moisture level, texture and elasticity, reduce fine lines and promote skin cells regeneration. Super fruits – pomegranate, acai, acerola and grapeseed, are rich in antioxidants to protect skin from free radicals. Vitamins E and A helps to accelerate skin cells regeneration and maintain skin surface condition. Combining great product properties and affordable pricing, Diva offers a convenient and healthy way for women to take better care of their skin from the inside.

Surabaya, 20 March 2014 – PT Kalbe Farma Tbk (Kalbe) In collaboration with the Ministry of Research and Technology of the Republic of Indonesia (MRT RI) today holds a National seminar with the theme of "Optimization of Academics, Industry, and Government to Devise Superior and Implementable National Research" as part of the Ristek-Kalbe Science Awards (RKSA) 2014 activities, at Graha BIK IPTEK-DOK, Faculty of Medicine, Airlangga University. The Ristek-Kalbe Science Awards itself is an event to appreciate the best researchers in Indonesia. The seminar that was attended by 150 researchers and academics presented speakers from the academics, business, and government parties.

Bogor, 8 March 2014 – PT Kalbe Farma Tbk (Kalbe) through its subsidiary PT Bifarma Adiluhung today launches its ReGeniC (Regenerative and Cellular Therapy) brand. ReGeniC is the service unit on Stem Cell and education center on stem cell services for the public.  In the event that is attended by 11 chairpersons of Indonesian hospitals that has the license to do stem cell services, a number of development on the science and regulations on stem cells.